公开(公告)号：WO2018119762A1

公开(公告)日：2018-07-05

申请号：PCT/CN2016/112682

申请日：2016-12-28

申请人： L'OREAL ,  XU, Zhen

发明人： XU, Zhen

IPC分类号： A61K8/02 ,  A61K8/92 ,  A61K8/85 ,  A61K8/37 ,  A61Q1/04 ,  A61Q1/08

摘要： The present invention relates to a solid anhydrous composition for caring for and/or making up keratin materials comprising, a) greater than or equal to 5 ％ of at least one oil chosen from fatty acid triglycerides, relative to the total weight of the composition, b) at least one pasty compound chosen from an ester of dimer dilinoleic acid and polyol (s) or an ester thereof, and c) at least one wax of solid linear ester derived from C 6 -C 30 fatty acid. The present invention also relates to a process for caring for and/or making up keratin materials such as the skin and the lips, preferably the lips, by applying the solid anhydrous composition according to the present invention to the keratin materials.

公开(公告)号：WO2017008243A1

公开(公告)日：2017-01-19

申请号：PCT/CN2015/083964

申请日：2015-07-14

申请人： L'OREAL ,  XU, Zhen

发明人： XU, Zhen

IPC分类号： A61K8/92 ,  A61Q1/02 ,  A61Q1/04 ,  A61Q1/06

CPC分类号： A61K8/925 ,  A61K8/0216 ,  A61K8/0229 ,  A61K8/31 ,  A61K8/342 ,  A61K8/37 ,  A61K8/375 ,  A61K8/8111 ,  A61K8/92 ,  A61K8/922 ,  A61K2800/31 ,  A61K2800/43 ,  A61K2800/592 ,  A61K2800/5922 ,  A61Q1/02 ,  A61Q1/04 ,  A61Q1/06

摘要： Disclosed is, in general, a solid anhydrous composition for application onto a targeted substrate. More particularly, disclosed is a non-liquid anhydrous composition with a combination of waxes, comprising a) at least one wax with a melting point greater than or equal to 60℃; b) at least one wax, different from a), of solid linear ester derived from C6-C30 fatty acid, c) at least one nonvolatile oil, and d) at least one pasty compound, wherein the weight ratio of a) and b) is from 1 to 4.

摘要翻译： 通常公开了一种用于施加到目标基底上的固体无水组合物。 更具体地，公开了一种具有蜡组合的非液体无水组合物，其包含a）至少一种熔点大于或等于60℃的蜡; b）至少一种不同于a）的来自C6-C30脂肪酸的固体直链酯的蜡，c）至少一种不挥发性油，和d）至少一种糊状化合物，其中a）和b的重量比 ）为1〜4。

公开(公告)号：WO2012075725A9

公开(公告)日：2013-04-11

申请号：PCT/CN2011070796

申请日：2011-01-30

申请人： CHANG ZHOU CURRENT SUPPLY COMPANY OF JIANGSU ELECTRIC POWER COMPANY ,  JIANGSU ELECTRIC POWER CO ,  STATE GRID CORP CHINA ,  CAO LIANG ,  HE HAO ,  YU JIANYANG ,  LUO JIAOHONG ,  XU ZHEN

发明人： CAO LIANG ,  HE HAO ,  YU JIANYANG ,  LUO JIAOHONG ,  XU ZHEN

IPC分类号： H02H7/16

CPC分类号： H02H3/08 ,  H02H7/16

摘要： A harmonic wave protecting method for a capacitor bank, which uses a harmonic wave protecting device for the capacitor ban including: a CPU unit (20), a current and voltage sampling unit (21) and a protecting device (23). The CPU unit (20) obtains the effective value of fundamental current It and the effective value of harmonic wave current In in the capacitor bank, and then calculates the true effective value of current I in the capacitor bank according the following equation (I), wherein kn is the nth harmonic wave factor, n is the harmonic order. The CPU unit (20) controls the protecting device (23) to cut off the capacitor bank when

摘要翻译： 一种用于电容器组的谐波保护方法，其使用用于电容器禁止的谐波保护装置，包括：CPU单元（20），电流和电压采样单元（21）和保护装置（23）。 CPU单元（20）获得基波电流It的有效值和电容器组中的谐波电流In的有效值，然后根据下式（I）计算电容器组中的电流I的真实有效值， 其中kn是第n个谐波因子，n是谐波次数。 当<= 1.3IN时，CPU单元（20）控制保护装置（23）切断电容器组，其中IN是电容器组的额定电流。

公开(公告)号：WO2012129722A1

公开(公告)日：2012-10-04

申请号：PCT/CN2011/000535

申请日：2011-03-29

申请人： L'ORÉAL ,  XU, Zhen ,  KONGMANY, Céline ,  DELAUNAY, Caroline

发明人： XU, Zhen ,  KONGMANY, Céline ,  DELAUNAY, Caroline

IPC分类号： A61K8/36 ,  A61Q1/06 ,  A61Q15/00

CPC分类号： A61K8/06 ,  A61K8/31 ,  A61K8/345 ,  A61K8/37 ,  A61K8/375 ,  A61K8/922 ,  A61Q19/001

摘要： A solid cosmetic composition in the form of oil-in-water emulsion for making up and/or caring for the skin and/or lips is described. The composition comprises from 1% to 15% by weight of C16-C25 linear fatty acid salts, at least 20% by weight of water and at least one fatty phase comprising oil and/or pasty fatty compounds in a physiologically acceptable medium.

摘要翻译： 描述了用于补充和/或照顾皮肤和/或嘴唇的水包油乳液形式的固体化妆品组合物。 所述组合物包含1至15重量％的C16-C25直链脂肪酸盐，至少20重量％的水和至少一种包含油和/或糊状脂肪化合物在生理学上可接受的介质中的脂肪相。

公开(公告)号：WO2011028609A3

公开(公告)日：2011-06-16

申请号：PCT/US2010046810

申请日：2010-08-26

申请人： UNIV MICHIGAN ,  CAIN CHARLES A ,  HALL TIMOTHY L ,  ROBERTS WILLIAM R ,  XU ZHEN ,  FOWLKES J BRIAN ,  DAVISON THOMAS W

发明人： CAIN CHARLES A ,  HALL TIMOTHY L ,  ROBERTS WILLIAM R ,  XU ZHEN ,  FOWLKES J BRIAN ,  DAVISON THOMAS W

IPC分类号： A61B17/225 ,  A61B6/12 ,  A61B8/00 ,  A61B18/26

CPC分类号： A61N7/00 ,  A61B8/00 ,  A61B17/225 ,  A61B17/2256 ,  A61B2017/00172 ,  A61B2017/22008 ,  A61B2090/378

摘要： A medical imaging and therapy device is provided that may include any of a number of features. One feature of the device is that it can deliver Lithotripsy therapy to a patient, so as to fractionate urinary stones. Another feature of the device is that it can deliver Histotripsy therapy to a patient, so as to erode urinary stones. In some embodiments, the medical imaging and therapy device is configured to target and track urinary stones in the patient during therapy. Methods associated with use of the medical imaging and therapy device are also covered.

摘要翻译： 提供了可以包括许多特征中的任何一个的医学成像和治疗装置。 该装置的一个特征是它可以向病人提供Lithotripsy治疗，以便分泌尿石。 该装置的另一个特征是可以将Histotripsy治疗方法提供给患者，以便侵蚀尿石。 在一些实施例中，医学成像和治疗装置被配置为在治疗期间靶向和跟踪患者的尿石。 还涉及与使用医学成像和治疗装置相关的方法。

公开(公告)号：WO2011028609A2

公开(公告)日：2011-03-10

申请号：PCT/US2010/046810

申请日：2010-08-26

申请人： THE REGENTS OF THE UNIVERSITY OF MICHIGAN ,  CAIN, Charles A. ,  HALL, Timothy L. ,  ROBERTS, William R. ,  XU, Zhen ,  FOWLKES, J. Brian ,  DAVISON, Thomas W.

发明人： CAIN, Charles A. ,  HALL, Timothy L. ,  ROBERTS, William R. ,  XU, Zhen ,  FOWLKES, J. Brian ,  DAVISON, Thomas W.

IPC分类号： A61B17/225 ,  A61B18/26 ,  A61B6/12 ,  A61B8/00

CPC分类号： A61N7/00 ,  A61B8/00 ,  A61B17/225 ,  A61B17/2256 ,  A61B2017/00172 ,  A61B2017/22008 ,  A61B2090/378

摘要： A medical imaging and therapy device is provided that may include any of a number of features. One feature of the device is that it can deliver Lithotripsy therapy to a patient, so as to fractionate urinary stones. Another feature of the device is that it can deliver Histotripsy therapy to a patient, so as to erode urinary stones. In some embodiments, the medical imaging and therapy device is configured to target and track urinary stones in the patient during therapy. Methods associated with use of the medical imaging and therapy device are also covered.

摘要翻译： 提供了一种医学成像和治疗设备，其可以包括许多特征中的任何特征。 该装置的一个特点是它可以为患者提供碎石治疗，以便分泌尿道结石。 该装置的另一个特点是它可以为病人提供组织治疗疗法，从而消除泌尿系结石。 在一些实施例中，医疗成像和治疗装置被配置为在治疗期间靶向和追踪患者的泌尿结石。 还包括与使用医疗成像和治疗设备相关的方法。

公开(公告)号：WO2014154113A1

公开(公告)日：2014-10-02

申请号：PCT/CN2014/073858

申请日：2014-03-21

申请人： L'OREAL ,  XU, Zhen

发明人： XU, Zhen ,  HUANG, Manlian

IPC分类号： A61K8/44 ,  A61K8/88 ,  A61K8/02 ,  A61Q1/00

CPC分类号： A61Q19/001 ,  A61K8/042 ,  A61K8/342 ,  A61K8/37 ,  A61K8/442 ,  A61K8/8111

摘要： A transparent composition comprising: a) at least one non polymeric organogelator selected from N-acryl glutamic acid diamide having a linear or branched chain alkyl group; b) at least one ester of dextrin and a fatty acid; c) at least one non-volatile oil phase, comprising from 30% to 95% by weight, relative to the total weight of the composition, of at least one non-volatile polar oil, and from 5% to 70% by weight, relative to the total weight of the composition, of at least one non-volatile apolar oil; d) optionally at least one amide or ester terminated polyamide of formula (I), X(COR 2 CONHR 3 NH) n COR 2 COX (I) Wherein : X represents-N(R 1 ) 2 group or -OR 1 group, where R 1 represents C 8-20 linear chain or branched chain alkyl group which may be same or different from each other, R 2 represents a dimer acid residue, R 3 represents an ethylenediamine residue, n represents an integer from 2 to 4, wherein if exists, the polyamide of formula (I) is present less than 10% by weight, relative to the total weight of the composition.

摘要翻译： 一种透明组合物，其包含：a）至少一种选自具有直链或支链烷基的N-丙烯酰谷氨酸二酰胺的非聚合物有机凝胶; b）至少一种糊精和脂肪酸酯; c）至少一种非挥发性油相，相对于组合物的总重量为30重量％至95重量％的至少一种非挥发性极性油，和5重量％至70重量％ 相对于组合物的总重量，至少一种非挥发性非极性油; d）任选的至少一种式（I）的酰胺或酯封端的聚酰胺，X（COR2CONHR3NH）nCOR2COX（I）其中：X代表-N（R1）2基团或-OR1基团，其中R1代表C8-20直链或 支链烷基可以相同或不同，R2表示二聚酸残基，R3表示乙二胺残基，n表示2-4的整数，如果存在，式（I）的聚酰胺的含量较少 相对于组合物的总重量为10重量％以下。

公开(公告)号：WO2011028603A2

公开(公告)日：2011-03-10

申请号：PCT/US2010046794

申请日：2010-08-26

申请人： UNIV MICHIGAN ,  ROBERTS WILLIAM W ,  HALL TIMOTHY L ,  CAIN CHARLES A ,  FOWLKES J BRIAN ,  XU ZHEN ,  KUSNER MICHAEL THOMAS JR ,  TEOFILOVIC DEJAN

发明人： ROBERTS WILLIAM W ,  HALL TIMOTHY L ,  CAIN CHARLES A ,  FOWLKES J BRIAN ,  XU ZHEN ,  KUSNER MICHAEL THOMAS JR ,  TEOFILOVIC DEJAN

IPC分类号： A61N7/00 ,  A61B8/00 ,  A61B8/13 ,  B25J7/00

CPC分类号： A61N7/02 ,  A61B8/12 ,  A61B8/4218 ,  A61B34/72 ,  A61B90/50 ,  A61B2017/22008 ,  A61B2090/378

摘要： A medical imaging and therapy device is provided that may include any of a number of features. One feature of the device is that it can image a target tissue volume and apply ultrasound energy to the target tissue volume. In some embodiments, the medical imaging and therapy device is configured controllably apply ultrasound energy into the prostate by maintaining a cavitational bubble cloud generated by an ultrasound therapy system within an image of the prostate generated by an imaging system. The medical imaging and therapy device can be used in therapeutic applications such as Histotripsy, Lithotripsy, and HIFU, for example. Methods associated with use of the medical imaging and therapy device are also covered.

摘要翻译： 提供了可以包括许多特征中的任何一个的医学成像和治疗装置。 该装置的一个特点是可以对目标组织体积进行成像，并将超声能量应用于目标组织体积。 在一些实施例中，医疗成像和治疗装置被配置为可控制地将超声能量施加到前列腺中，通过维持由成像系统产生的前列腺图像内的超声治疗系统产生的空泡气泡云。 医学成像和治疗装置可用于治疗应用，例如组织切除术，碎石术和HIFU。 还涉及与使用医学成像和治疗装置相关的方法。

公开(公告)号：WO2021177326A1

公开(公告)日：2021-09-10

申请号：PCT/JP2021/008030

申请日：2021-02-24

申请人： L'OREAL ,  NAKAYAMA Kana ,  XU Zhen

发明人： NAKAYAMA Kana ,  XU Zhen

IPC分类号： A61Q1/10 ,  A61K8/81 ,  A61K8/92

摘要： The present invention relates to a composition comprising: (a) at least one first liposoluble film-forming polymer selected from vinylester (co)polymers; (b) at least one second liposoluble film-forming polymer selected from polyester of polyvinyl alcohol and fatty acid; (c) at least one oil; and (d) at least one wax, wherein the amount of the (a) first film-forming polymer is from 0.4% to 3.0% by weight, preferably from 0.6% to 2.8% by weight, and more preferably from 0.8% to 2.6% by weight, relative to the total weight of the composition, and the amount of the (b) second film-forming polymer is from 0.2% to 2.0% by weight, preferably from 0.3% to 1.8% by weight, and more preferably from 0.4% to 1.6% by weight, relative to the total weight of the composition. The composition according to the present invention can provide keratin fibers such as eyelashes with cosmetic effects, such as volume-increasing effects, which can last for a long time of period, without smudging, while the composition according to the present invention can be easily removed from the keratin fibers.

公开(公告)号：WO2013130520A1

公开(公告)日：2013-09-06

申请号：PCT/US2013/027901

申请日：2013-02-27

申请人： BOSE CORPORATION ,  XU, Zhen ,  PARKER, Robert Preston ,  GRAFF, Allen T.

发明人： XU, Zhen ,  PARKER, Robert Preston ,  GRAFF, Allen T.

IPC分类号： H04R7/18 ,  H04R31/00

CPC分类号： H04R7/18 ,  H04R31/003 ,  H04R2231/003

摘要： A surround for supporting a diaphragm used to create acoustic waves includes a plurality of first rib sections extending away from the diaphragm and a second rib section having a zigzag pattern and being secured to an end of each of the first rib sections. As the diaphragm starts moving away from a home position in an intended direction of travel which is substantially perpendicular to a plane in which the diaphragm lies when the diaphragm is in the home position, the zigzag pattern of the second rib section starts to straighten out.

摘要翻译： 用于支撑用于产生声波的隔膜的环绕件包括从隔膜延伸的多个第一肋条部分和具有Z字形图案并固定到每个第一肋条部分的端部的第二肋部分。 当隔膜开始在预定的行进方向上离开原点位置时，当膜片处于原位时，其基本上垂直于隔膜所在的平面，第二肋区段的之字形图案开始变直。